Intensive insulin therapy and pentastarch resuscitation in severe sepsis

The New England Journal of Medicine
Frank M BrunkhorstGerman Competence Network Sepsis (SepNet)

Abstract

The role of intensive insulin therapy in patients with severe sepsis is uncertain. Fluid resuscitation improves survival among patients with septic shock, but evidence is lacking to support the choice of either crystalloids or colloids. In a multicenter, two-by-two factorial trial, we randomly assigned patients with severe sepsis to receive either intensive insulin therapy to maintain euglycemia or conventional insulin therapy and either 10% pentastarch, a low-molecular-weight hydroxyethyl starch (HES 200/0.5), or modified Ringer's lactate for fluid resuscitation. The rate of death at 28 days and the mean score for organ failure were coprimary end points. The trial was stopped early for safety reasons. Among 537 patients who could be evaluated, the mean morning blood glucose level was lower in the intensive-therapy group (112 mg per deciliter [6.2 mmol per liter]) than in the conventional-therapy group (151 mg per deciliter [8.4 mmol per liter], P<0.001). However, at 28 days, there was no significant difference between the two groups in the rate of death or the mean score for organ failure. The rate of severe hypoglycemia (glucose level, < or = 40 mg per deciliter [2.2 mmol per liter]) was higher in the intensive-therapy group ...Continue Reading

References

May 30, 1996·The New England Journal of Medicine·R ThadhaniJ V Bonventre
Jul 17, 1998·Clinical and Diagnostic Laboratory Immunology·E A van RijenR A Little
Sep 1, 2001·The New England Journal of Medicine·A P Jonville-BéraY Gruel
Jan 17, 2002·The New England Journal of Medicine·G van den BergheR Bouillon
Dec 18, 2002·Annals of Internal Medicine·Johannes J A AuwerdaPieter Sonneveld
Feb 11, 2003·Critical Care Medicine·Greet Van den BerghePeter Lauwers
Jun 18, 2003·The American Journal of the Medical Sciences·Mark A Perazella
Jul 2, 2003·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Jean-Michel LietJean-Christophe Rozé
Apr 20, 2004·Critical Care Medicine·R Phillip DellingerUNKNOWN Surviving Sepsis Campaign Management Guidelines Committee
May 12, 2004·Archives of Surgery·Michael E BarronRoberta J Navickis
May 28, 2004·The New England Journal of Medicine·Philip E Cryer
Jul 28, 2004·Anesthesiology·Gary R HaynesKim J Payne
Nov 2, 2004·Wiener klinische Wochenschrift·Christian J Wiedermann
Nov 2, 2004·Wiener klinische Wochenschrift·Joachim Boldt
Apr 9, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Evangeline PilleboutDenis Glotz
Feb 3, 2006·The New England Journal of Medicine·Greet Van den BergheRoger Bouillon
Apr 13, 2006·European Journal of Haematology·Martin Schmidt-HieberMichael Notter
Jan 11, 2007·Diabetes Care·Mark WilsonGuy W Soo Hoo
Jan 26, 2007·British Journal of Anaesthesia·Y SakrJ-L Vincent

❮ Previous
Next ❯

Citations

Aug 5, 2008·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Philip Jones
Dec 4, 2008·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Lauralyn A McIntyreUNKNOWN Canadian Critical Care Trials Group
Oct 7, 2011·Medizinische Klinik, Intensivmedizin und Notfallmedizin·C J Wiedermann
Jun 14, 2013·Medizinische Klinik, Intensivmedizin und Notfallmedizin·M HeckerK Mayer
Mar 5, 2013·Medizinische Klinik, Intensivmedizin und Notfallmedizin·G ElkeUNKNOWN German Competence Network Sepsis (SepNet)
May 21, 2013·Medizinische Klinik, Intensivmedizin und Notfallmedizin·U Holzinger
Feb 14, 2008·Der Anaesthesist·J Briegel
Jun 28, 2008·Der Anaesthesist·K ReinhartUNKNOWN Deutsche Studiengruppe Kompetenznetzwerk Sepsis (SepNet)
Apr 21, 2010·Der Anaesthesist·M BernhardM A Weigand
Aug 10, 2010·Der Anaesthesist·V MannM Bernhard
Feb 26, 2011·Der Anaesthesist·B NohéK Unertl
May 12, 2012·Der Anaesthesist·A SchneiderP Teschendorf
Jun 5, 2012·Der Anaesthesist·M HeckerK Mayer
Sep 8, 2012·Der Anaesthesist·P KellnerC Raspé
Oct 23, 2012·Der Anaesthesist·G PestelM M Weber
Jan 16, 2013·Der Anaesthesist·D SchädlerUNKNOWN German Competence Network Sepsis (SepNet)
May 27, 2008·Intensive Care Medicine·Gabriel J HauserThomas M Fishbein
May 28, 2008·Intensive Care Medicine·Gaetano IapichinoLuciano Gattinoni
Aug 8, 2008·Intensive Care Medicine·Frédérique SchortgenUNKNOWN CRYCO Study Group
Aug 8, 2008·Intensive Care Medicine·Patrick M HonoreWillem Boer
Oct 8, 2008·Intensive Care Medicine·Daniel A SweeneyCharles Natanson
Oct 8, 2008·Intensive Care Medicine·Peter M Suter, Jukka Takala
Feb 18, 2009·Intensive Care Medicine·Georges MionAudrey Cirodde
Jun 10, 2009·Intensive Care Medicine·Valentin FuhrmannChristian Madl
Jun 18, 2009·Intensive Care Medicine·Christiane Hartog, Konrad Reinhart
Sep 18, 2009·Intensive Care Medicine·Michael C ReadeDerek C Angus
Nov 19, 2009·Intensive Care Medicine·Michael JoannidisUNKNOWN Critical Care Nephrology Working Group of the European Society of Intensive Care Medicine
Nov 3, 2009·Intensive Care Medicine·Ursula G KyleLarry S Jefferson
Nov 6, 2009·Intensive Care Medicine·Martin Alexander SchickChristian Wunder
Dec 3, 2009·Intensive Care Medicine·Christiane S HartogMaximilian Ragaller
Mar 12, 2010·Intensive Care Medicine·Gustavo Ospina-TasconDaniel De Backer
May 14, 2010·Intensive Care Medicine·Frédérique SchortgenUNKNOWN CRYCO Study Group
Jan 7, 2011·Intensive Care Medicine·Iain M J MackenziePeter G Nightingale

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved